Mechanisms, precision therapies, and technological frontiers in coronary atherosclerosis: a comprehensive review.
Saved in:
| Title: | Mechanisms, precision therapies, and technological frontiers in coronary atherosclerosis: a comprehensive review. |
|---|---|
| Authors: | Qiu ZX; Center for Drug Safety Evaluation and Research of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China., Wang RY; Center for Drug Safety Evaluation and Research of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China., Zhang Y; Center for Drug Safety Evaluation and Research of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China., Huang HB; Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia., He RY; Department of Pharmaceutical Preparation, Hangzhou Xixi Hospital, Hangzhou, Zhejiang, China., Yan H; Center for Drug Safety Evaluation and Research of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China., Luo PH; Center for Drug Safety Evaluation and Research of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.; Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, Hangzhou, Zhejiang, China., Yang B; Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, Hangzhou, Zhejiang, China.; Institute of Pharmacology & Toxicology, Zhejiang Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.; School of Medicine, Hangzhou City University, Hangzhou, Zhejiang, China., Xu ZF; Center for Drug Safety Evaluation and Research of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China. xzfzjut@zju.edu.cn., He QJ; Center for Drug Safety Evaluation and Research of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China. qiaojunhe@zju.edu.cn.; Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, Hangzhou, Zhejiang, China. qiaojunhe@zju.edu.cn.; School of Medicine, Hangzhou City University, Hangzhou, Zhejiang, China. qiaojunhe@zju.edu.cn. |
| Source: | Acta pharmacologica Sinica [Acta Pharmacol Sin] 2026 May; Vol. 47 (5), pp. 1103-1116. Date of Electronic Publication: 2026 Jan 27. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 100956087 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1745-7254 (Electronic) Linking ISSN: 16714083 NLM ISO Abbreviation: Acta Pharmacol Sin Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41593207 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Mechanisms, precision therapies, and technological frontiers in coronary atherosclerosis: a comprehensive review. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Qiu+ZX%22">Qiu ZX</searchLink>; Center for Drug Safety Evaluation and Research of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.<br /><searchLink fieldCode="AU" term="%22Wang+RY%22">Wang RY</searchLink>; Center for Drug Safety Evaluation and Research of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Center for Drug Safety Evaluation and Research of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.<br /><searchLink fieldCode="AU" term="%22Huang+HB%22">Huang HB</searchLink>; Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22He+RY%22">He RY</searchLink>; Department of Pharmaceutical Preparation, Hangzhou Xixi Hospital, Hangzhou, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Yan+H%22">Yan H</searchLink>; Center for Drug Safety Evaluation and Research of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.<br /><searchLink fieldCode="AU" term="%22Luo+PH%22">Luo PH</searchLink>; Center for Drug Safety Evaluation and Research of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.; Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, Hangzhou, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Yang+B%22">Yang B</searchLink>; Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, Hangzhou, Zhejiang, China.; Institute of Pharmacology & Toxicology, Zhejiang Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.; School of Medicine, Hangzhou City University, Hangzhou, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Xu+ZF%22">Xu ZF</searchLink>; Center for Drug Safety Evaluation and Research of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China. xzfzjut@zju.edu.cn.<br /><searchLink fieldCode="AU" term="%22He+QJ%22">He QJ</searchLink>; Center for Drug Safety Evaluation and Research of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China. qiaojunhe@zju.edu.cn.; Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, Hangzhou, Zhejiang, China. qiaojunhe@zju.edu.cn.; School of Medicine, Hangzhou City University, Hangzhou, Zhejiang, China. qiaojunhe@zju.edu.cn. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100956087%22">Acta pharmacologica Sinica</searchLink> [Acta Pharmacol Sin] 2026 May; Vol. 47 (5), pp. 1103-1116. <i>Date of Electronic Publication: </i>2026 Jan 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100956087 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1745-7254 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216714083%22">16714083 </searchLink><i>NLM ISO Abbreviation: </i>Acta Pharmacol Sin <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41593207 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41401-025-01729-x Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1103 Titles: – TitleFull: Mechanisms, precision therapies, and technological frontiers in coronary atherosclerosis: a comprehensive review. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Qiu ZX – PersonEntity: Name: NameFull: Wang RY – PersonEntity: Name: NameFull: Zhang Y – PersonEntity: Name: NameFull: Huang HB – PersonEntity: Name: NameFull: He RY – PersonEntity: Name: NameFull: Yan H – PersonEntity: Name: NameFull: Luo PH – PersonEntity: Name: NameFull: Yang B – PersonEntity: Name: NameFull: Xu ZF – PersonEntity: Name: NameFull: He QJ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1745-7254 Numbering: – Type: volume Value: 47 – Type: issue Value: 5 Titles: – TitleFull: Acta pharmacologica Sinica Type: main |
| ResultId | 1 |
